Decision test 01
Is the question genuinely mechanistic?
A strong concept must identify a causal uncertainty, not merely another association with chronological age.
Research programme
Longevity and aging biology define the search space; the strategic focus is the bridge from genetic and omics signals to protein structure, molecular function, proteostasis and computational systems inference. The lead concept remains under selection.
Scientific architecture
Longevity is the thematic frame. The fundable scientific object must emerge from a narrower, defensible and person-specific research question.
Decision test 01
A strong concept must identify a causal uncertainty, not merely another association with chronological age.
Decision test 02
The experimental and computational design must expose the central proposition to meaningful falsification.
Decision test 03
Every measurement layer must answer a defined question and connect to the programme's causal logic.
Decision test 04
Novelty, expertise, access, timing, risk and validation must remain coherent at programme scale.
Research domains
These domains define the search space; they do not yet constitute a selected study or funded project.
Mechanistic study of how biological function changes across molecular, cellular and systemic scales.
Sequence variation, genome architecture and regulatory landscapes.
Joint analysis of genomic, epigenomic, transcriptomic and proteomic layers.
Three-dimensional biomolecular structure and its relation to function.
Physical principles governing molecular stability, dynamics and interaction.
Reproducible computational analysis of large-scale biological data.
Network-level models of interacting biological components and states.
Inter-individual biological variation and heterogeneous trajectories.
Connecting mechanistic questions with potential clinical relevance.
Determinants of healthspan, resilience and variation in biological aging.
Development logic
The programme is deliberately built in sequence: verified capability first, then horizon scanning, validated knowledge gaps, concept competition and only then a selected experimental programme.
Verify publications, methods, independence and scientific trajectory for the candidate researchers.
Map frontier aging biology, emerging technologies, contradictions and unresolved mechanisms.
Identify questions whose scientific importance extends beyond descriptive biomarker discovery.
Validate where current mechanistic explanation genuinely ends using current primary evidence.
Generate a broad portfolio of serious, person-specific frontier-research directions.
Score and red-team candidate concepts for novelty, PI fit, high-risk/high-gain and feasibility.
Select one research question only after novelty, competition and scientific fit survive deep review.
Build hypotheses, aims, methods, validation, statistics, risks and alternative strategies around the selected concept.
Candidate directions
The current list is exploratory. Status labels describe concept maturity only.
Why some biological systems maintain function longer than others.
Separating potentially causal molecular changes from correlates of age.
Connecting heterogeneous molecular layers into interpretable models.
How molecular structure and protein dynamics may relate to loss of function.
Understanding heterogeneous biological trajectories between individuals.
Programme development
The grant narrative follows the science. A proposal architecture is developed only after a coherent scientific concept survives profile, novelty and feasibility review.
Phase 01
Verify expertise, track record, methods and available research capability.
Phase 02
Map the current field, emerging methods and competing research directions.
Phase 03
Identify open questions with genuine mechanistic and conceptual value.
Phase 04
Formulate candidate programmes with explicit assumptions and hypotheses.
Phase 05
Evaluate novelty, feasibility, fit and scientific significance.
Phase 06
Specify models, controls, power, analysis and validation strategy.
Phase 07
Plan the evidence needed to de-risk central scientific assumptions.
Phase 08
Structure objectives, work packages, risks and resources.
Phase 09
Draft, challenge and revise the scientific case.
Phase 10
Complete compliance, consistency and quality assurance.